BALYASNY ASSET MANAGEMENT L.P. - 30 Sep 2025 SCHEDULE 13G Report for Avalo Therapeutics Inc. Common Stock, par value $0.001 per share (AVTX)

Filing Manager
BALYASNY ASSET MANAGEMENT L.P.
Reporting Manager
Balyasny Asset Management L.P.
Security
Avalo Therapeutics Inc. Common Stock, par value $0.001 per share
Symbol
AVTX
Shares outstanding
13,142,058 shares
Disclosed Ownership
817,436 shares
Ownership
6.2%
Form type
SCHEDULE 13G
Filing time
14 Nov 2025, 06:01:14 UTC
Date of event
30 Sep 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Balyasny Asset Management L.P. 6.2% 817,436 817,436 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
BAM GP LLC 6.2% 817,436 817,436 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Balyasny Asset Management Holdings LP 6.2% 817,436 817,436 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dames GP LLC 6.2% 817,436 817,436 0 /s/ Scott Schroeder Scott Schroeder / Authorized Signatory
Dmitry Balyasny 6.2% 817,436 817,436 0 /s/ Dmitry Balyasny Dmitry Balyasny / Self